Announcing HistoSonics and IHPBA Partnership

The International Hepato-Pancreato-Biliary Association (IHPBA) is pleased to announce a new partnership with HistoSonics, a company developing innovative focused ultrasound technologies for the treatment of liver disease.

The partnership will support professional education and scientific exchange within the global HPB community, with a focus on emerging approaches and ongoing research in liver care. Through collaborative activities, IHPBA and HistoSonics aim to foster dialogue and engagement among clinicians, researchers, and thought leaders worldwide.

“IHPBA’s mission is to support education, collaboration, and the exchange of scientific ideas across the global HPB community,” said René Adam, President of IHPBA. “This partnership with HistoSonics reflects our commitment to fostering informed dialogue around emerging technologies and encouraging thoughtful discussion on innovations that may influence the future of liver cancer treatment.”

From HistoSonics’ perspective, the collaboration underscores the importance of engagement with the clinical and research community. “We are pleased to collaborate with IHPBA in support of education and scientific exchange within the HPB field,” saidKjirsten O’Brien Director, Society Partnerships & Engagements at HistoSonics. “Engaging with clinicians and researchers through organizations like IHPBA is essential to advancing understanding of new therapeutic approaches and supporting ongoing research in liver tumors.”

This collaboration reflects a shared interest in advancing knowledge and supporting informed discussion around new technologies that may shape the future of HPB medicine.

Corporate Partnership Disclaimer: This partnership is intended to facilitate professional dialogue, education, and potential future research. It does not constitute an endorsement by IHPBA of HistoSonics or its products, services, or technologies.

Published on Wednesday 4th February 2026